HB 296 – Maryland

Status: Inactive / Dead
Year Introduced: 2019
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb0296&stab=01&pid=billpage&tab=subject3&ys=2019RS

Requiring, at the point of sale, a certain pharmacist or the pharmacist’s designee to inform a retail consumer, to the best of the pharmacist’s or pharmacist’s designee’s knowledge, of the retail price for a prescription drug and, under certain circumstances, the cost share for which the retail consumer is responsible for the prescription drug; and requiring the State Board of Pharmacy to adopt certain procedures.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found